Plasma levels of glutamate during stroke is associated with development of post-stroke depression

Psychoneuroendocrinology

Volumn 47, Issue , 2014, Pages 126-135

  Cheng, Sai Yu ^a   Zhao, Yan Dong ^a   Li, Jie ^a   Chen, Xiao Yan ^a   Wang, Ruo Dan ^a   Zeng, Jun Wei ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Chinese; Depression; Glutamate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUTAMIC ACID BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROLOGIC EXAMINATION; PATHOGENESIS; POST STROKE DEPRESSION; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; STROKE PATIENT; TANDEM MASS SPECTROMETRY; AGED; BLOOD; COMPLICATION; HOSPITAL ADMISSION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84903722847     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.05.006     Document Type: Article

References (50)

1. Aben I., Verhey F., Strik J.J.M.H., Lousberg R., Lodder J., Honig A. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J. Neurol. Neurosurg. Psychiatry 2003, 74:581-585.
2. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., Marsh E. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
3. Aliprandi A., Longoni M., Stanzani L., Tremolizzo L., Vaccaro M., Begni B., Ferrarese C. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J. Cereb. Blood Flow Metab. 2005, 25:513-519.
4. Almeida O.P., Marsh K., Alfonso H., Flicker L., Davis T.M., Hankey G.J. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann. Neurol. 2010, 68:503-510.
5. Auer D.P., Pütz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 2000, 47:305-313.
6. Bonita R.B.R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988, 19:1497-1500.
7. Bonnet C.S., Williams A.S., Gilbert S.J., Harvey A.K., Evans B.A., Mason D.J. AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann. Rheum. Dis. 2013, (Epub ahead of print). 10.1136/annrheumdis-2013-203670.
8. Brasier D.J., Feldman D.E. Synapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortex. J. Neurosci. 2008, 28:2199-2211.
9. Brott T., Adams H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
10. Campos F., Rodriguez-Yanez M., Castellanos M., Arias S., Perez-Mato M., Sobrino T., Castillo J. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels. Clin. Sci. (Lond) 2011, 121:11-17.
11. Campos F., Sobrino T., Ramos-Cabrer P., Argibay B., Agulla J., Pérez-Mato M., Castillo J. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J. Cereb. Blood Flow Metab. 2011, 31:1378-1386.
12. Castillo J., Dávalos A., Naveiro J., Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996, 27:1060-1065.
13. Castillo J., Dávalos A., Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997, 349(9045):79-83.
14. Croarkin P.E., Nakonezny P.A., Husain M.M., Melton T., Buyukdura J.S., Kennard B.D., Daskalakis Z.J. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry 2013, 70:291-299.
15. Dai S.S., Zhou Y.G., Li W., An J.H., Li P., Yang N., Chen J.F. Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J. Neurosci. 2010, 30:5802-5810.
16. Ellis C., Zhao Y., Egede L.E. Depression and increased risk of death in adults with stroke. J. Psychosom. Res. 2010, 68:545-551.
17. Farner L., Wagle J., Engedal K., Flekkøy K.M., Wyller T.B., Fure B. Depressive symptoms in stroke patients: a 13month follow-up study of patients referred to a rehabilitation unit. J. Affect. Disord. 2010, 127:211-218.
18. First M.B., Spitzer R.L., Gibbon M. Structured Clinical Interview for DSM-IV axis I Disorders - Patient Edition (SCID-I/P, version 2.0) 1995, Biometrics Research Department, New York State Psychiatric Institute, New York.
19. Fuentes B., Ortiz X., Sanjose B., Frank A., Díez-Tejedor E. Post-stroke depression: can we predict its development from the acute stroke phase?. Acta Neurol. Scand. 2009, 120:150-156.
20. Gauthier C., Hassler C., Mattar L., Launay J.M., Callebert J., Steiger H., Godart N. Symptoms of depression and anxiety in anorexia nervosa: links with plasma tryptophan and serotonin metabolism. Psychoneuroendocrinology 2014, 39:170-178.
21. Gómez-Galán M., De Bundel D., Van Eeckhaut A., Smolders I., Lindskog M. Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression. Mol. Psychiatry 2012, 18:582-594.
22. Hadidi N., Treat-Jacobson D.J., Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung 2009, 38:151-162.
23. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
24. Jimenez I., Sobrino T., Rodriguez-Yanez M., Pouso M., Cristobo I., Sabucedo M., Castillo J. High serum levels of leptin are associated with post-stroke depression. Psychol. Med. 2009, 39:1201-1209.
25. Kim J.M., Stewart R., Bae K.Y., Kim S.W., Kang H.J., Shin I.S., Yoon J.S. Serotonergic and BDNF genes and risk of depression after stroke. J. Affect. Disord. 2012, 136:833-840.
26. Küçükibrahimoǧlu E., Saygin M.Z., Çalişkan M., Kaplan O.K., Ünsal C., Gören M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine-or S-citalopram-treated female patients with major depression. Eur. J. Clin. Pharmacol. 2009, 65:571-577.
27. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 1999, 4:317-327.
28. Liu L., Wang D., Wong K.L., Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011, 42:3651-3654.
29. Masskulpan P., Riewthong K., Dajpratham P., Kuptniratsaikul V. Anxiety and depressive symptoms after stroke in 9 rehabilitation centers. J. Med. Assoc. Thai. 2008, 91:1595-1602.
30. Mazereeuw G., Herrmann N., Bennett S.A., Swardfager W., Xu H., Valenzuela N., LanctÔt K.L. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. Neurosci. Biobehav. Rev. 2013, 37:1611-1621.
31. McEwen A.M., Burgess D.T., Hanstock C.C., Seres P., Khalili P., Newman S.C., LeMelledo J.M. Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology 2012, 37:2428-2435.
32. McNally L., Bhagwagar Z., Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008, 13:501-510.
33. Mitchell N.D., Baker G.B. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr. Scand. 2010, 122:192-210.
34. Musazzi L., Treccani G., Mallei A., Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol. Psychiatry 2013, 73:1180-1188.
35. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr. Dis. Treat. 2008, 4:145-154.
36. Pascoe M.C., Crewther S.G., Carey L.M., Noonan K., Crewther D.P., Linden T. Homocysteine as a potential biochemical marker for depression in elderly stroke survivors. Food. Nutr. Res. 2012, 56.
37. Puig N.U.R., Dávalos A., Adan J., Piulats J., Martinez J.M., Castillo J.E. Serum amino acid levels after permanent middle cerebral artery occlusion in the rat. Cerebrovasc. Dis. 2000, 10:449-454.
38. Rink C., Gnyawali S., Peterson L., Khanna S. Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid. Redox Signal. 2011, 14:1777-1785.
39. Robinson R.G., Spalletta G. Poststroke depression: a review. Can. J. Psychiatry 2010, 55:341-349.
40. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
41. Sims J.R., Gharai L.R., Schaefer P.W., Vangel M., Rosenthal E.S., Lev M.H., Schwamm L.H. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009, 72:2104-2110.
42. Tang W.K., Chan S.S., Chiu H.F., Wong K.S., Kwok T.C., Mok V., Ungvari G.S. Can the Geriatric Depression Scale detect poststroke depression in Chinese elderly?. J. Affect. Disord. 2004, 81:153-156.
43. Tang W.K., Liang H., Chu W.C.W., Mok V., Ungvari G.S., Wong K.S. Association between high serum total bilirubin and post-stroke depression. Psychiatry Clin. Neurosci. 2013, 67:259-264.
44. Teichberg V.I., Cohen-Kashi-Malina K., Cooper I., Zlotnik A. Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 2009, 158:301-308.
45. Tiemeier H. Biological risk factors for late life depression. Eur. J. Epidemiol. 2003, 18:745-750.
46. Tokita K., Yamaji T., Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol. Biochem. Behav. 2012, 100:688-704.
47. Wang X., Li Y.H., Li M.H., Lu J., Zhao J.G., Sun X.J., Ye J.L. Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur. Arch. Psychiatry Neurol. Sci. 2012, 262:33-38.
48. Whyte E.M., Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol. Psychiatry 2002, 52:253-264.
49. Zhang T., Wang C., Liu L., Zhao X., Xue J., Zhou Y., Wang Y. A prospective cohort study of the incidence and determinants of post-stroke depression among the mainland Chinese patients. Neurol. Res. 2010, 32:347-352.
50. Zlotnik A., Gurevich B., Tkachov S., Maoz I., Shapira Y., Teichberg V.I. Brain neuroprotection by scavenging blood glutamate. Exp. Neurol. 2007, 203:213-220.